We Go Together: Johnson & Johnson on tal...

Futurist and author Jacob Morgan has a plan for building future-ready organizations: cultivating a thriving, accountable workforce; embracing flexibility; and applying technology to foster resilience and employee growth.Future-ready organizations track change early, plan proactiv ... Show More

Retail real estate’s comeback is undeniable. Investor Adam Ifshin details how open-air retail once again became a preferred institutional asset. Recorded at ICSC Las Vegas, Adam discusses the appeal of secondary markets, value-add strategies and the reasons why real estate operat ... Show More

Private club entrepreneur Tommy Shuey and CBRE’s Kelly Whaley discuss how these venues fill a growing need for personalized service and engagement outside the home or office, while driving value for both property owners and local communities.· A new “third place” is emerging: Pri ... Show More

In this episode, David Lebovitz, Global Strategist, Multi-Asset Solutions, is joined by Stephen Squinto, Chief Investment Officer, J.P. Morgan Life Sciences Private Capital, to discuss the alternative investment landscape, the private biotech market and areas of opportunity in 20 ... Show More

Hemant Taneja, a managing director at General Catalyst and the founder of the firm’s Silicon Valley operations, joins Scott to discuss the venture capital space, why he’s bullish on the healthcare sector, and why responsible innovation is more important than ever. Hemant also sha ... Show More

Artemeter founder and CEO Olivia Albrecht discusses her firm and the intersection of climate science, capital markets and product innovation. She speaks with Carol Massar and Romaine Bostick from the 28th annual Milken Institute Global Conference in Beverly Hills See omnystudio.c ... Show More

How can corporates and entrepreneurs build ventures together? In this episode, Elise Carton (PwC) explores the benefits and challenges of this exciting form of corporate venturing.Her guests Sam Heymans (CEO and founder of Lizy) and Michaël Grandfils (Managing Director of Lab Box ... Show More

Oruka Therapeutics CEO Lawrence Klein joins us to discuss how his company raised its first round of financing before competing with major players in the inflammation space. We also discuss the latest news in the life sciences, including the end of the Amylyx ALS saga, another use ... Show More

Barron's senior managing editor Lauren R. Rublin and healthcare industry reporter Josh Nathan-Kazis discuss the outlook for healthcare stocks, and the latest news on Covid-19 treatments and vaccines. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information ab ... Show More

Entrepreneurs discuss how much money you need to start a business - and where to get it from - with Evan Davis.Why do some start-ups require millions and others just a few hundred pounds? And what are the benefits and pitfalls of finding investors on the web? It's called crowd-fu ... Show More